To apply for an EIND the disease must be considered serious or life threatening I don't know if the FDA would consider Lyme disease either. One can only try. The first step would be to contact Cytodyn. The second would be for the doctor to get written consent from the patient and approval from the Institutional Review Board at their hospital. Next step contact the FDA.

The other option would be off-label use when leronlimab is approved for any indication.